The Weekly Roundup: October 31-November 4

ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.

POLL: Have You Treated Generalized Pustular Psoriasis in Your Practice?

Click here to answer this week's poll.

Pathogenesis of Plaque Psoriasis

Mark G. Lebwohl, MD, and Alice B. Gottlieb, MD, PhD, discuss pathogenesis of plaque psoriasis and new emerging targets.

Treatment Selection for Plaque Psoriasis

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss how to select treatment for plaque psoriasis based on mechanism of action.

What's Trending in Skin Care: October 2022

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of October.

Morgellons Disease: A Mysterious Disease

MD is a type of delusional parasitosis where patients report that their skin contains parasites, toxins, fibers, or other foreign material.

A Changing Treatment Landscape in Atopic Dermatitis

Raj Chovatiya, MD, PhD, and Lisa Swanson, MD, FAAD, review the recent trajectory of the atopic dermatitis therapeutic spectrum, notably how several newer approvals have changed how clinicians approach treatment.

The JAK-STAT Pathway and the Mechanisms of JAK Inhibitors

Thought leaders discuss why JAK inhibitors are well suited for the management of itch and inflammation in the treatment of moderate to severe atopic dermatitis.

PROMs Rarely Used in Randomized Clinical Trials for Acne and Rosacea

Patient-reported outcome measures ensure patients' experiences are documented during new treatments.

Erythropoietic Protoporphyria: A Brief Review

Erythropoietic protoporphyria (EPP) is a life-long and debilitating disorder resulting from defects in the enzymes in heme synthesis. Patients with the disease are cast indoors due to extreme photosensitivity.

Epidermolysis Bullosa: The Worst Disease You’ve Never Heard Of

Epidermolysis bullosa is a broad term used to identify a group of genetic disorders that result in skin blistering and fragility.

BPDCN: More Than Just a Rash

Blastic plasmacytoid dendritis cell neoplasm is a rare and aggressive form of cancer that usually makes its appearance in the form of red to violet papules and plaques.

CMS Looks to Make Changes on Codes for Skin Wounds

The Centers for Medicare and Medicaid Services is looking to change the way cellular and/or tissue-based products for skin wounds are coded and paid for in physician offices.

New Study Champions Honey to Help Wounds Heal

Honey has long been known to have remarkable antimicrobial and tissue-regenerative properties.

Will Kirby, DO, FAOCD, Talks With Dustin Portela, DO, FAAD

Will Kirby, DO, FAOCD, talks with Dustin Portela, DO, FAAD, about TikTok, what being a KOL really means, and the biggest aesthetic myth in the industry right now.

Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic Dermatitis

Recent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.

Plaque Psoriasis Treatment Gets Even More Company

Nonsteroidal topical agents and TYK2 inhibitors may join an already full armamentarium.

Innovations in Neuromodulators

Seth Matarasso, MD, discusses upcoming innovations in neuromodulators and additional highlights from his presentation at ASDS in Denver, Colorado.

Warning: Concerning Levels of Benzene Detected in Dry Shampoo Products

Christopher Bunick, MD, PhD, shares his thoughts on the latest report of concerning levels of benzene, a human carcinogen, found in dry shampoos recalled last month.